Physician profile
Randall Pace
NPI 1932337466
$5,141.08
in general payments reported to CMS, 2019-2025
55 companies · $981 in 2025
The $981 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $209 · 2021: $598 · 2022: $982 · 2023: $808 · 2024: $1,045 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,834.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,372.10 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $400.52 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Takeda Pharmaceuticals U.S.A., INC. | $276.92 | 2019-2025 | Trintellix |
| Tris Pharma INC | $242.97 | 2019-2025 | Dyanavel Xr |
| Sanofi Pasteur INC. | $167.20 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.49 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Supernus Pharmaceuticals, INC. | $150.64 | 2021-2024 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $136.23 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Corium, LLC | $126.99 | 2022-2025 | Azstarys |
| Pfizer INC. | $123.18 | 2019-2025 | |
| Astellas Pharma US INC | $119.93 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $116.74 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $109.26 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $93.41 | 2023-2025 | Spravato |
| Ironshore Pharmaceuticals INC. | $82.66 | 2022-2024 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Pace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.